{"entity":{"type":"insider","cik":"0001346948","url":"/insider/0001346948","json_url":"/insider/0001346948.json","name":"FHM V, LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":966,"n_filings":46,"first":"2007-04-09","last":"2017-01-31","span_basis":"filed_date"},"name_variants":[{"name":"FHM V, LP","source":"filing","n_filings":46,"first_seen":"2007-04-09","last_seen":"2017-01-31"}],"transactions":[{"id":5012346,"accession":"0001012975-17-000069","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001012975-17-000069","line_url":"/filing/0001012975-17-000069","is_derivative":false,"issuer_cik":"0001018534","issuer_name":"ANAPTYSBIO INC","issuer_ticker":"ANAB","issuer_name_source":null,"issuer_url":"/issuer/0001018534","owner_cik":null,"owner_name":"Naini Nader J; FRAZIER ALAN D; Heron Patrick J; Frazier Healthcare V, LP; FHM V, LLC; FHM V, LP; Every Nathan R","owner_display_name":"Naini Nader J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":6000000.0,"total_display":"6,000,000.00","total_whole":"6,000,000","shares_owned_after":311291.0,"shares_owned_after_display":"311,291","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-01-31","filed_date":"2017-01-31","scope":"insider","n_lines":2},{"id":5652717,"accession":"0001209191-09-011695","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-011695","line_url":"/filing/0001209191-09-011695#line-1","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FHM V, LLC; FHM V, LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1662000.0,"shares_display":"1,662,000","price_per_share":0.0727,"price_display":"0.07","price_state":"stated","total_value":120827.4,"total_display":"120,827.40","total_whole":"120,827","shares_owned_after":5470555.0,"shares_owned_after_display":"5,470,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-24","filed_date":"2009-02-26","scope":"insider"},{"id":5700072,"accession":"0001181431-09-010498","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-09-010498","line_url":"/filing/0001181431-09-010498","is_derivative":false,"issuer_cik":"0001333248","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001333248","owner_cik":null,"owner_name":"FHM VI, L.P.; Frazier Healthcare V, LP; FHM V, LLC; FHM VI, L.L.C.; FHM V, LP; Frazier Healthcare VI, L.P.","owner_display_name":"FHM VI, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10427526.0,"shares_display":"10,427,526","price_per_share":7.13,"price_display":"7.13","price_state":"stated","total_value":74348260.38,"total_display":"74,348,260.38","total_whole":"74,348,260","shares_owned_after":3128258.0,"shares_owned_after_display":"3,128,258","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-02-18","filed_date":"2009-02-20","scope":"insider","n_lines":6},{"id":3484155,"accession":"0001144204-08-014370","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001144204-08-014370","line_url":"/filing/0001144204-08-014370","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FRAZIER AFFILIATES IV LP; FHM IV LP; FHM V, LP; FHM V, LLC; FRAZIER HEALTHCARE IV LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4740.0,"shares_display":"4,740","price_per_share":10.273457805907173,"price_display":"10.27","price_state":"stated","total_value":48696.19,"total_display":"48,696.19","total_whole":"48,696","shares_owned_after":919364.0,"shares_owned_after_display":"919,364","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-10","filed_date":"2008-03-10","scope":"insider","n_lines":17},{"id":2678817,"accession":"0001144204-08-014369","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0001144204-08-014369","line_url":"/filing/0001144204-08-014369","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FHM V, LLC; FRAZIER HEALTHCARE IV LP; FHM V, LP; FHM IV LP; FRAZIER AFFILIATES IV LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":760.0,"shares_display":"760","price_per_share":10.0675,"price_display":"10.07","price_state":"stated","total_value":7651.3,"total_display":"7,651.30","total_whole":"7,651","shares_owned_after":915764.0,"shares_owned_after_display":"915,764","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-10","filed_date":"2008-03-10","scope":"insider","n_lines":5},{"id":2678791,"accession":"0001144204-08-014369","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001144204-08-014369","line_url":"/filing/0001144204-08-014369#line-25","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FHM V, LLC; FRAZIER HEALTHCARE IV LP; FHM V, LP; FHM IV LP; FRAZIER AFFILIATES IV LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5263.0,"shares_display":"5,263","price_per_share":10.08,"price_display":"10.08","price_state":"stated","total_value":53051.04,"total_display":"53,051.04","total_whole":"53,051","shares_owned_after":913064.0,"shares_owned_after_display":"913,064","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-06","filed_date":"2008-03-10","scope":"insider"},{"id":2678781,"accession":"0001144204-08-014369","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001144204-08-014369","line_url":"/filing/0001144204-08-014369#line-24","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FHM V, LLC; FRAZIER HEALTHCARE IV LP; FHM V, LP; FHM IV LP; FRAZIER AFFILIATES IV LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2100.0,"shares_display":"2,100","price_per_share":9.98,"price_display":"9.98","price_state":"stated","total_value":20958.0,"total_display":"20,958.00","total_whole":"20,958","shares_owned_after":902996.0,"shares_owned_after_display":"902,996","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-06","filed_date":"2008-03-10","scope":"insider"},{"id":2678777,"accession":"0001144204-08-014369","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001144204-08-014369","line_url":"/filing/0001144204-08-014369#line-23","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FHM V, LLC; FRAZIER HEALTHCARE IV LP; FHM V, LP; FHM IV LP; FRAZIER AFFILIATES IV LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1800.0,"shares_display":"1,800","price_per_share":10.14,"price_display":"10.14","price_state":"stated","total_value":18252.0,"total_display":"18,252.00","total_whole":"18,252","shares_owned_after":915064.0,"shares_owned_after_display":"915,064","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-06","filed_date":"2008-03-10","scope":"insider"},{"id":2678771,"accession":"0001144204-08-014369","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001144204-08-014369","line_url":"/filing/0001144204-08-014369#line-22","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FHM V, LLC; FRAZIER HEALTHCARE IV LP; FHM V, LP; FHM IV LP; FRAZIER AFFILIATES IV LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1300.0,"shares_display":"1,300","price_per_share":9.985,"price_display":"9.98","price_state":"stated","total_value":12980.5,"total_display":"12,980.50","total_whole":"12,981","shares_owned_after":904296.0,"shares_owned_after_display":"904,296","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-06","filed_date":"2008-03-10","scope":"insider"},{"id":2678768,"accession":"0001144204-08-014369","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001144204-08-014369","line_url":"/filing/0001144204-08-014369#line-21","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FHM V, LLC; FRAZIER HEALTHCARE IV LP; FHM V, LP; FHM IV LP; FRAZIER AFFILIATES IV LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1100.0,"shares_display":"1,100","price_per_share":9.995,"price_display":"10.00","price_state":"stated","total_value":10994.5,"total_display":"10,994.50","total_whole":"10,995","shares_owned_after":905796.0,"shares_owned_after_display":"905,796","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-06","filed_date":"2008-03-10","scope":"insider"},{"id":2678763,"accession":"0001144204-08-014369","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001144204-08-014369","line_url":"/filing/0001144204-08-014369#line-20","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FHM V, LLC; FRAZIER HEALTHCARE IV LP; FHM V, LP; FHM IV LP; FRAZIER AFFILIATES IV LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1100.0,"shares_display":"1,100","price_per_share":9.93,"price_display":"9.93","price_state":"stated","total_value":10923.0,"total_display":"10,923.00","total_whole":"10,923","shares_owned_after":894810.0,"shares_owned_after_display":"894,810","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-06","filed_date":"2008-03-10","scope":"insider"},{"id":2678759,"accession":"0001144204-08-014369","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001144204-08-014369","line_url":"/filing/0001144204-08-014369#line-19","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FHM V, LLC; FRAZIER HEALTHCARE IV LP; FHM V, LP; FHM IV LP; FRAZIER AFFILIATES IV LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":9.955,"price_display":"9.96","price_state":"stated","total_value":9955.0,"total_display":"9,955.00","total_whole":"9,955","shares_owned_after":897102.0,"shares_owned_after_display":"897,102","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-06","filed_date":"2008-03-10","scope":"insider"},{"id":2678756,"accession":"0001144204-08-014369","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001144204-08-014369","line_url":"/filing/0001144204-08-014369#line-18","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FHM V, LLC; FRAZIER HEALTHCARE IV LP; FHM V, LP; FHM IV LP; FRAZIER AFFILIATES IV LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":993.0,"shares_display":"993","price_per_share":9.96,"price_display":"9.96","price_state":"stated","total_value":9890.28,"total_display":"9,890.28","total_whole":"9,890","shares_owned_after":898095.0,"shares_owned_after_display":"898,095","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-06","filed_date":"2008-03-10","scope":"insider"},{"id":2678752,"accession":"0001144204-08-014369","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001144204-08-014369","line_url":"/filing/0001144204-08-014369#line-17","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FHM V, LLC; FRAZIER HEALTHCARE IV LP; FHM V, LP; FHM IV LP; FRAZIER AFFILIATES IV LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":868.0,"shares_display":"868","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":8680.0,"total_display":"8,680.00","total_whole":"8,680","shares_owned_after":907464.0,"shares_owned_after_display":"907,464","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-06","filed_date":"2008-03-10","scope":"insider"},{"id":2678748,"accession":"0001144204-08-014369","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001144204-08-014369","line_url":"/filing/0001144204-08-014369#line-16","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FHM V, LLC; FRAZIER HEALTHCARE IV LP; FHM V, LP; FHM IV LP; FRAZIER AFFILIATES IV LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":9.9975,"price_display":"10.00","price_state":"stated","total_value":7998.0,"total_display":"7,998.00","total_whole":"7,998","shares_owned_after":906596.0,"shares_owned_after_display":"906,596","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-06","filed_date":"2008-03-10","scope":"insider"},{"id":2678743,"accession":"0001144204-08-014369","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001144204-08-014369","line_url":"/filing/0001144204-08-014369#line-15","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FHM V, LLC; FRAZIER HEALTHCARE IV LP; FHM V, LP; FHM IV LP; FRAZIER AFFILIATES IV LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":9.9675,"price_display":"9.97","price_state":"stated","total_value":7974.0,"total_display":"7,974.00","total_whole":"7,974","shares_owned_after":899495.0,"shares_owned_after_display":"899,495","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-06","filed_date":"2008-03-10","scope":"insider"},{"id":2678738,"accession":"0001144204-08-014369","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001144204-08-014369","line_url":"/filing/0001144204-08-014369#line-14","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FHM V, LLC; FRAZIER HEALTHCARE IV LP; FHM V, LP; FHM IV LP; FRAZIER AFFILIATES IV LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":9.935,"price_display":"9.94","price_state":"stated","total_value":7948.0,"total_display":"7,948.00","total_whole":"7,948","shares_owned_after":895610.0,"shares_owned_after_display":"895,610","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-06","filed_date":"2008-03-10","scope":"insider"},{"id":2678733,"accession":"0001144204-08-014369","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001144204-08-014369","line_url":"/filing/0001144204-08-014369#line-13","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FHM V, LLC; FRAZIER HEALTHCARE IV LP; FHM V, LP; FHM IV LP; FRAZIER AFFILIATES IV LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600.0,"shares_display":"600","price_per_share":9.965,"price_display":"9.96","price_state":"stated","total_value":5979.0,"total_display":"5,979.00","total_whole":"5,979","shares_owned_after":898695.0,"shares_owned_after_display":"898,695","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-06","filed_date":"2008-03-10","scope":"insider"},{"id":2678730,"accession":"0001144204-08-014369","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001144204-08-014369","line_url":"/filing/0001144204-08-014369#line-12","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FHM V, LLC; FRAZIER HEALTHCARE IV LP; FHM V, LP; FHM IV LP; FRAZIER AFFILIATES IV LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":501.0,"shares_display":"501","price_per_share":9.9775,"price_display":"9.98","price_state":"stated","total_value":4998.7275,"total_display":"4,998.73","total_whole":"4,999","shares_owned_after":900896.0,"shares_owned_after_display":"900,896","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-06","filed_date":"2008-03-10","scope":"insider"},{"id":2678724,"accession":"0001144204-08-014369","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001144204-08-014369","line_url":"/filing/0001144204-08-014369#line-11","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FHM V, LLC; FRAZIER HEALTHCARE IV LP; FHM V, LP; FHM IV LP; FRAZIER AFFILIATES IV LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":9.9725,"price_display":"9.97","price_state":"stated","total_value":4986.25,"total_display":"4,986.25","total_whole":"4,986","shares_owned_after":900395.0,"shares_owned_after_display":"900,395","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-06","filed_date":"2008-03-10","scope":"insider"},{"id":2678720,"accession":"0001144204-08-014369","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001144204-08-014369","line_url":"/filing/0001144204-08-014369#line-10","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FHM V, LLC; FRAZIER HEALTHCARE IV LP; FHM V, LP; FHM IV LP; FRAZIER AFFILIATES IV LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":9.92,"price_display":"9.92","price_state":"stated","total_value":4960.0,"total_display":"4,960.00","total_whole":"4,960","shares_owned_after":893710.0,"shares_owned_after_display":"893,710","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-06","filed_date":"2008-03-10","scope":"insider"},{"id":2678714,"accession":"0001144204-08-014369","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001144204-08-014369","line_url":"/filing/0001144204-08-014369#line-9","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FHM V, LLC; FRAZIER HEALTHCARE IV LP; FHM V, LP; FHM IV LP; FRAZIER AFFILIATES IV LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":9.99,"price_display":"9.99","price_state":"stated","total_value":3996.0,"total_display":"3,996.00","total_whole":"3,996","shares_owned_after":904696.0,"shares_owned_after_display":"904,696","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-06","filed_date":"2008-03-10","scope":"insider"},{"id":2678703,"accession":"0001144204-08-014369","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001144204-08-014369","line_url":"/filing/0001144204-08-014369#line-8","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FHM V, LLC; FRAZIER HEALTHCARE IV LP; FHM V, LP; FHM IV LP; FRAZIER AFFILIATES IV LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":9.97,"price_display":"9.97","price_state":"stated","total_value":3988.0,"total_display":"3,988.00","total_whole":"3,988","shares_owned_after":899895.0,"shares_owned_after_display":"899,895","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-06","filed_date":"2008-03-10","scope":"insider"},{"id":2678698,"accession":"0001144204-08-014369","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001144204-08-014369","line_url":"/filing/0001144204-08-014369#line-7","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FHM V, LLC; FRAZIER HEALTHCARE IV LP; FHM V, LP; FHM IV LP; FRAZIER AFFILIATES IV LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":10.01,"price_display":"10.01","price_state":"stated","total_value":3003.0,"total_display":"3,003.00","total_whole":"3,003","shares_owned_after":907764.0,"shares_owned_after_display":"907,764","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-06","filed_date":"2008-03-10","scope":"insider"}],"collapsed":true,"next_cursor":"2008-03-06|2678698","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001370053","name":"ANAPTYSBIO INC","url":"/issuer/0001370053","role":"Ten percent owner","n_filings":1,"first_seen":"2017-01-31","last_seen":"2017-01-31"},{"type":"issuer","type_label":"ISSUER","cik":"0000920465","name":"LA JOLLA PHARMACEUTICAL CO","url":"/issuer/0000920465","role":"Ten percent owner","n_filings":2,"first_seen":"2007-04-09","last_seen":"2009-02-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001333248","name":"CADENCE PHARMACEUTICALS INC","url":"/issuer/0001333248","role":"Ten percent owner","n_filings":1,"first_seen":"2009-02-20","last_seen":"2009-02-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001178879","name":"AMICUS THERAPEUTICS INC","url":"/issuer/0001178879","role":"Ten percent owner","n_filings":39,"first_seen":"2007-06-29","last_seen":"2008-03-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001003464","name":"ENDOCARE INC","url":"/issuer/0001003464","role":"Ten percent owner","n_filings":3,"first_seen":"2007-12-13","last_seen":"2008-01-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001346948","retrieved_at":"2026-08-23T03:05:48+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}